Koyfin Home > Directory > Health Care > Acceleron Pharma > Price / Earnings (ltm)

Acceleron Pharma Price / Earnings (ltm) Chart (XLRN)

Acceleron Pharma annual/quarterly Price / Earnings (ltm) from 2013 to 2013. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Acceleron Pharma Price / Earnings (ltm) for the quarter ending November 11, 2013 was 46.38 a -5.03% decrease of -2.33 year over year
  • Acceleron Pharma Price / Earnings (ltm) for the last 12 months ending November 11, 2013 was 46.38 a -5.03% decrease of -2.33 year over year
  • Acceleron Pharma Annual Price / Earnings (ltm) for 2013 was 46.38 a 5.50% increase of 2.55 from 2012
  • Acceleron Pharma Annual Price / Earnings (ltm) for 2013 was 43.83 a -4.73% decrease of -2.07 from 2012
  • Acceleron Pharma Annual Price / Earnings (ltm) for 2013 was 45.91 a -6.12% decrease of -2.81 from 2012
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin

Quarterly XLRN Price / Earnings (ltm) Data

11/201346.38
11/201343.83
11/201345.91
10/201348.72
10/201349.39
10/201349.15
10/201351.35
10/201349.39
10/201350.25
10/201349.84

Annual XLRN Price / Earnings (ltm) Data

201346.38
201343.83
201345.91
201348.72
201349.39
201349.15
201351.35
201349.39
201350.25
201349.84